Award
NIH Reporter #1R43CA295316-01A1
Development of a metabolomics enabled AI/ML platform for discovery of new treatments to enhance drug sensitivity in cancer
Recipient
SINOPIA BIOSCIENCES, INC.
Award Amount
$285,599.00
Ceiling
$285,599.00
Awarded
September 18, 2025
Identifier
1R43CA295316-01A1
Award for developing an AI/ML platform using metabolomics to discover new cancer treatments enhancing drug sensitivity, funded by NCI/NIH.
Description
The project focuses on developing a metabolomics-based AI/ML platform for cancer treatment discovery. It involves high-throughput metabolomics analysis of cancer cell lines and development of computational algorithms to identify metabolic signatures predictive of drug sensitivity and resistance. Funded by the National Cancer Institute (NCI), part of NIH, with collaboration with biotech/pharma partners aiming for further development into preclinical models.